Cytomegalovirus Experience in Pediatric Kidney Transplantation in 26 Years’ Time
dc.contributor.author | Keskinoglu, A. | |
dc.contributor.author | Bulut, İ.K. | |
dc.contributor.author | Taner, S. | |
dc.contributor.author | Turkes, A.Z. | |
dc.contributor.author | Kabasakal, C. | |
dc.date.accessioned | 2020-12-01T11:52:19Z | |
dc.date.available | 2020-12-01T11:52:19Z | |
dc.date.issued | 2020 | |
dc.department | Ege Üniversitesi | en_US |
dc.description.abstract | Introduction: In this study,we investigated the presence of cytomegalovirus (CMV) infection in kidney transplanted children and its effect on kidney dysfunction. Material and Methods: One hundred thirty-five pediatric renal transplant patients were included in this study. The presence of CMV infection, CMV risk status, and other clinical features of the patients were evaluated retrospectively. Results: Fifty-three percent of all patients and 68.8% of patients with CMV were male. The mean age was 12 years in all patients and CMV groups. According to the CMV risk classification, 40.9% of the patients with CMV infection/disease were in the high-risk group (CMV D+R-). In CMV risk groups, the presence of CMV infection/disease was similar. Cold ischemia time, male sex (patients and donors), deceased donor, higher HLA-mismatches, and cumulative antithymocyte globulin dose were found as risk factors for CMV infection/disease. Acute rejection/graft failure was observed in 27% of all patients. CMV infection has no effect on rejection/graft failure and survival. Discussion: The frequency and risk factors of CMV in renal transplant children in our study were consistent with the literature. Conclusions: CMV infection was found in one-fifth of our patients and the majority (71.9%) of them developed infection in the first 6 months. In one-third of our patients acute rejection/graft failure was observed. There was no effect of CMV infection on rejection/graft failure and survival in pediatric patients with proper and effective treatment. © 2020 | en_US |
dc.description.sponsorship | We would like to thank Prof Dr Pembe Keskino?lu for data analysis and their collaborations in this study. | en_US |
dc.identifier.doi | 10.1016/j.transproceed.2020.03.023 | en_US |
dc.identifier.endpage | 3191 | en_US |
dc.identifier.issn | 0041-1345 | |
dc.identifier.issue | 10 | en_US |
dc.identifier.pmid | 32646585 | en_US |
dc.identifier.scopus | 2-s2.0-85087527485 | en_US |
dc.identifier.scopusquality | Q3 | en_US |
dc.identifier.startpage | 3186 | en_US |
dc.identifier.uri | https://doi.org/10.1016/j.transproceed.2020.03.023 | |
dc.identifier.uri | https://hdl.handle.net/11454/61502 | |
dc.identifier.volume | 52 | en_US |
dc.indekslendigikaynak | Scopus | en_US |
dc.indekslendigikaynak | PubMed | en_US |
dc.language.iso | en | en_US |
dc.publisher | Elsevier Inc. | en_US |
dc.relation.ispartof | Transplantation Proceedings | en_US |
dc.relation.publicationcategory | Makale - Uluslararası Hakemli Dergi - Kurum Öğretim Elemanı | en_US |
dc.rights | info:eu-repo/semantics/closedAccess | en_US |
dc.title | Cytomegalovirus Experience in Pediatric Kidney Transplantation in 26 Years’ Time | en_US |
dc.type | Article | en_US |